Canaccord Genuity Raises Estimates on Nu Skin Enterprises (NUS); Lookin' Good
Tweet Send to a FriendGet Alerts NUS Hot Sheet
Price: $62.54 -0.41%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Trade NUS Now!
Canaccord Genuity reiterates a 'Buy' on Nu Skin Enterprises (NYSE: NUS) price target of $66.00.
Analyst, Scott Van Winkle, said, "Our thesis remains that Nu Skin is in the midst of a powerful product cycle, coupled with a concerted effort to improve margins that should drive above-average EPS growth...Raising F2012 rev/EPS to $2.01B/$3.21 from $1.90B/$3.03. F2013 rev/EPS goes to $2.14B/$3.62 from $2.05B/$3.45."
For an analyst ratings summary and ratings history on Nu Skin Enterprises click here. For more ratings news on Nu Skin Enterprises click here.
Shares of Nu Skin Enterprises closed at $48.55 yesterday, with a 52 week range of $35.44-$62.02.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Scott Van Winkle, said, "Our thesis remains that Nu Skin is in the midst of a powerful product cycle, coupled with a concerted effort to improve margins that should drive above-average EPS growth...Raising F2012 rev/EPS to $2.01B/$3.21 from $1.90B/$3.03. F2013 rev/EPS goes to $2.14B/$3.62 from $2.05B/$3.45."
For an analyst ratings summary and ratings history on Nu Skin Enterprises click here. For more ratings news on Nu Skin Enterprises click here.
Shares of Nu Skin Enterprises closed at $48.55 yesterday, with a 52 week range of $35.44-$62.02.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- Goldman Sachs Upgrades Meritor (MTOR) to Buy
- Brean Capital Raises Onyx (ONXX) Price Target to $115
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
Canaccord Genuity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
